The SPARC study aimed to evaluate the diagnostic accuracy, cost-effectiveness, and prognostic value of different imaging modalities by assessing their use in patients with suspected coronary artery disease (CAD). The study began in 2006 with over 1,700 participants across 41 sites in the United States of America and Canada. Participants were followed up for 2 years, at various intervals, including after 90 days, 1 year and 2 years.
Study design
Cohort - clinical
Number of participants at first data collection
1,717 (participants)
Age at first data collection
Varied (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Countries
Year of first data collection
2006
Primary Institutions
Cleveland Clinic
Brigham and Women’s Hospital (BWH)
Cardiac Specialists
Cardiovascular Associates
Cedars-Sinai Medical Center
Profile paper DOI
Funders
Astellas Pharma Inc. (アステラス製薬株式会社)
Bracco
GE HealthCare
Siemens Healthineers
Ongoing?
No
Data types collected
Engagement
Keywords